应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01099 国药控股
交易中 05-06 10:36:40
20.000
+0.380
+1.94%
最高
20.200
最低
19.700
成交量
257.32万
今开
19.700
昨收
19.620
日振幅
2.55%
总市值
624.13亿
流通市值
268.36亿
总股本
31.21亿
成交额
5,155万
换手率
0.19%
流通股本
13.42亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
国药控股05月03日主力资金流入1367万元 连续3日加仓
自选股智能写手 · 05-03 16:15
国药控股05月03日主力资金流入1367万元 连续3日加仓
《大行》高盛微降国药(01099.HK)目标价至21.17元 首季业绩疲弱
阿斯达克财经 · 05-02
《大行》高盛微降国药(01099.HK)目标价至21.17元 首季业绩疲弱
国药控股(01099.HK):主营业务保持增长态势 转型创新持续推进
中金公司 · 04-30
国药控股(01099.HK):主营业务保持增长态势 转型创新持续推进
《大行》大摩降国药(01099.HK)目标价至27元 评级“增持”
阿斯达克财经 · 04-30
《大行》大摩降国药(01099.HK)目标价至27元 评级“增持”
《蓝筹》国药控股(01099.HK)首季纯利14.2亿元人民币跌10.7%
阿斯达克财经 · 04-29
《蓝筹》国药控股(01099.HK)首季纯利14.2亿元人民币跌10.7%
港股异动 | 国药控股(01099)绩后跌超10% 一季度归母净利同比下滑逾一成
智通财经 · 04-29
港股异动 | 国药控股(01099)绩后跌超10% 一季度归母净利同比下滑逾一成
【港股通】国药控股(01099)绩后跌近9% 首季归母净利按年跌10.7%
金吾财讯 · 04-29
【港股通】国药控股(01099)绩后跌近9% 首季归母净利按年跌10.7%
港股国药控股跌幅扩大至10%
每日经济新闻 · 04-29
港股国药控股跌幅扩大至10%
国药控股(01099.HK)跌近一成 上季少赚10.7%
阿斯达克财经 · 04-29
国药控股(01099.HK)跌近一成 上季少赚10.7%
南向资金4月26日净买入国药控股85.88万股 连续7日增持
自选股智能写手 · 04-29
南向资金4月26日净买入国药控股85.88万股 连续7日增持
国药(01099.HK)拟发行共300亿人币非金融企业债务融资工具
阿斯达克财经 · 04-29
国药(01099.HK)拟发行共300亿人币非金融企业债务融资工具
国药控股公布第一季度业绩 归母净利润约14.2亿元同比减少10.7%
新浪港股 · 04-29
国药控股公布第一季度业绩 归母净利润约14.2亿元同比减少10.7%
【港股通】国药控股(01099)首季归母净利同比减少10.7%至14.2亿元人民币
金吾财讯 · 04-29
【港股通】国药控股(01099)首季归母净利同比减少10.7%至14.2亿元人民币
国药控股(01099)拟在中国境内统一注册发行300亿元非金融企业债务融资工具额度
智通财经网 · 04-29
国药控股(01099)拟在中国境内统一注册发行300亿元非金融企业债务融资工具额度
国药控股(01099)公布第一季度业绩 归母净利约14.2亿元 同比减少10.7%
智通财经 · 04-29
国药控股(01099)公布第一季度业绩 归母净利约14.2亿元 同比减少10.7%
国药控股:国药股份一季度净利润4.59亿元 同比增长10.86%
新浪港股 · 04-26
国药控股:国药股份一季度净利润4.59亿元 同比增长10.86%
国药控股(01099):2024年第一季度营收超121亿,净利润同比增10.86%
和讯网 · 04-26
国药控股(01099):2024年第一季度营收超121亿,净利润同比增10.86%
国药(01099.HK)附属国药一致首季净利润3.89亿人民币 增长7.3%
阿斯达克财经 · 04-26
国药(01099.HK)附属国药一致首季净利润3.89亿人民币 增长7.3%
国药控股(01099):国药股份(600511.SH)一季度净利润4.59亿元,同比增长10.86%
智通财经 · 04-25
国药控股(01099):国药股份(600511.SH)一季度净利润4.59亿元,同比增长10.86%
泰通能源拟与国药控股开展融资租赁业务合作 融资金额为2000万
挖贝网 · 04-25
泰通能源拟与国药控股开展融资租赁业务合作 融资金额为2000万
暂无数据
公司概况
公司名称:
国药控股
所属市场:
SEHK
上市日期:
--
主营业务:
国药控股股份有限公司主要从事药品及医疗器械分销业务。该公司通过三个业务分部运营。医药分销分部向医院、其他分销商、零售药店及诊所等客户分销药物、医疗器械及医药制品。医药零售分部从事经营医药连锁店业务。其他业务分部从事分销实验室用品、制造及分销化学试剂、以及生产和销售医药制品业务。该公司还通过其子公司在中国从事提供医药物流服务及从事物业租赁业务。
发行价格:
--
{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"国药控股","latestPrice":20,"timestamp":1714962996532,"preClose":19.62,"halted":0,"volume":2573176,"delay":0,"floatShares":1341810740,"shares":3120656191,"eps":3.1459312,"marketStatus":"交易中","marketStatusCode":2,"change":0.38,"latestTime":"05-06 10:36:40","open":19.7,"high":20.2,"low":19.7,"amount":51548347,"amplitude":0.025484,"askPrice":20.05,"askSize":60800,"bidPrice":19.98,"bidSize":31600,"shortable":3,"etf":0,"ttmEps":3.0829965899758496,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1714968000000},"adr":0,"adjPreClose":19.62,"dividendRate":0.047443,"openAndCloseTimeList":[[1714959000000,1714968000000],[1714971600000,1714982400000]],"volumeRatio":1.291755,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK"},"requestUrl":"/m/hq/s/01099/tweets","defaultTab":"tweets","newsList":[{"id":"2432942227","title":"国药控股05月03日主力资金流入1367万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2432942227","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432942227?lang=zh_cn&edition=full","pubTime":"2024-05-03 16:15","pubTimestamp":1714724147,"startTime":"0","endTime":"0","summary":"05月03日, 国药控股股价涨1.03%,报收19.62元,成交金额1.08亿元,换手率0.41%,振幅2.99%,量比0.57。国药控股今日主力资金净流入1367万元,连续3日净流入,上一交易日主力净流入1479万元,今日环比减少7.57%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为42.11%,平均涨幅为1.14%。该股近5个交易日下跌9.98%,主力资金累计净流入6907万元;近20日主力资金累计净流入9427万元,其中净流入天数为13日。该股主力净额占比0.05%,港股市场排名81/2621。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050316160987cdcc60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050316160987cdcc60&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432864074","title":"《大行》高盛微降国药(01099.HK)目标价至21.17元 首季业绩疲弱","url":"https://stock-news.laohu8.com/highlight/detail?id=2432864074","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2432864074?lang=zh_cn&edition=full","pubTime":"2024-05-02 15:34","pubTimestamp":1714635240,"startTime":"0","endTime":"0","summary":"高盛发表研报指,国药(01099.HK) 今年首季业绩表现疲弱,主要是受到去年较高基数,以及行业监管措施的影响,期内销售额按年增长1.2%,逊于高盛预测的增长7%。报告指,受季节性因素影响,首季国药毛利率低于7%,销售额及毛利率拖累期内盈利表现,但管理层仍维持全年销售额增幅高于行业约两至三个百分点的指引不变,即预期余下几个季度增长情况将改善。因应最新业绩表现,高盛将国药2024至2026年纯利预测分别下调3.1%、3.4%及4.7%,维持“中性”评级,并下调目标价至21.17元。(gc/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-05-02 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180202161553962_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180202161553962_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1346988/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2431317989","title":"国药控股(01099.HK):主营业务保持增长态势 转型创新持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2431317989","media":"中金公司","top":-1,"share":"https://www.laohu8.com/m/news/2431317989?lang=zh_cn&edition=full","pubTime":"2024-04-30 19:16","pubTimestamp":1714475795,"startTime":"0","endTime":"0","summary":"发展趋势主营业务保持增长。核心子公司国药股份一季度收入121.2 亿元,同比增长7.98%;国药一致一季度收入190.9 亿元,同比增长2.16%。2024 年一季度,公司毛利率为7.2%,同比下降0.3 个百分点。我们认为公司未来有望通过优化业务结构,保持毛利率相对稳定。2024 年一季度,公司销售费用率为2.9%,管理费用率为1.2%,同比均基本持平。转型创新持续推进。风险药品集中采购压力,医药零售及医疗器械分销业务增长不及预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301916398b660a6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301916398b660a6d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431365079","title":"《大行》大摩降国药(01099.HK)目标价至27元 评级“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2431365079","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2431365079?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:20","pubTimestamp":1714461600,"startTime":"0","endTime":"0","summary":"大摩发表报告指,在国药控股(01099.HK) 公布首季业绩后,将2024至2030年盈利预期下调2%至5%,原因是医疗设备部门收入及毛利率预测被下调。同时增加应收账款天数估计。目标价由28元降至27元。评级“增持”。(ha/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-30 12:25。)AASTOCKS新闻","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190604131528273_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190604131528273_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1346441/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2431465885","title":"《蓝筹》国药控股(01099.HK)首季纯利14.2亿元人民币跌10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431465885","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2431465885?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:48","pubTimestamp":1714380480,"startTime":"0","endTime":"0","summary":"国药控股(01099.HK) 公布截至今年3月底止非国际会计准则首季业绩,营业额1,472.66亿元人民币(下同),按年升1.2%。纯利14.2亿元,按年跌10.7%;每股盈利0.46元。(js/cy)过往派息公布日期派息事项派息内容2024/03/22末期业绩普通股息:人民币 0.872023/10/27第三季业绩无派息2023/08/28中期业绩无派息2023/04/28第一季业绩无派息 (港股报价延迟最少十五分钟。沽空资料截至 2024-04-29 16:25。)AASTOCKS新闻","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190604131534109_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190604131534109_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345968/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2431929042","title":"港股异动 | 国药控股(01099)绩后跌超10% 一季度归母净利同比下滑逾一成","url":"https://stock-news.laohu8.com/highlight/detail?id=2431929042","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431929042?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:57","pubTimestamp":1714355833,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,国药控股(01099)绩后跌超10%,截至发稿,跌8.03%,报19.82港元,成交额1.13亿港元。消息面上,国药控股公布2024年第一季度业绩,营业总收入约1472.66亿元,同比增长1.2%;归属于母公司所有者的净利润约14.2亿元,同比减少10.7%。大摩此前指出,对该公司2024-2030年盈利预测下调3%-6%,主要原因是药品分销的销售以及毛利率降低,但评级仍予“增持”,原因包括该公司作为国企,是唯一一家中央政府持有的药品经销商,在内地药品分销商中处于领先地位,具有全国规模,能够提供强大的安全网。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042910002187bcc161&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042910002187bcc161&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431504175","title":"【港股通】国药控股(01099)绩后跌近9% 首季归母净利按年跌10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431504175","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2431504175?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:45","pubTimestamp":1714355136,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国药控股(01099)盘初股价下行,截止发稿,跌8.86%,报19.64港元,成交额8501.92万港元。公司业绩显示,截至2024年3月31日止三个月之季度,归母净利录得14.2亿元人民币,同比减少10.7%;营收录得1472.66亿元人民币,同比增长1.2%;基本每股收益0.46元人民币。","market":"sh","thumbnail":"https://static.szfiu.com/news/20200908/MDgyM2JhZGUzZDEwMDQ3MDAxNzk5NzY4NzQxNTI4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgyM2JhZGUzZDEwMDQ3MDAxNzk5NzY4NzQxNTI4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935951","is_publish_highlight":false,"gpt_icon":0},{"id":"2431044923","title":"港股国药控股跌幅扩大至10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431044923","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2431044923?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:45","pubTimestamp":1714355107,"startTime":"0","endTime":"0","summary":"港股国药控股跌幅扩大至10%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404293063323890.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404293063323890.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431042394","title":"国药控股(01099.HK)跌近一成 上季少赚10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431042394","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2431042394?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:41","pubTimestamp":1714354860,"startTime":"0","endTime":"0","summary":"国药今日低开1.6%后跌幅急剧扩大,最低见19.14元。现报19.48元,跌9.61%,成交295.72万股,涉资5,951.89万元。国药首季归属于母公司所有者的净利润按年下跌10.7%至约14.2亿元人民币,营业总收入按年增1.2%至约1,472.7亿元人民币。另外,集团宣布,建议在中国境内统一注册发行非金融企业债务融资工具额度,发行规模为300亿元人民币,以满足集团补充营运及备付资金的实际需求,保证直接融资渠道畅通,降低融资成本并改善债务结构。沽空资料截至 2024-04-26 16:25。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220907154100326_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220907154100326_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345742/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2431426020","title":"南向资金4月26日净买入国药控股85.88万股 连续7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2431426020","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431426020?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:31","pubTimestamp":1714354287,"startTime":"0","endTime":"0","summary":"4月26日, 南向资金增持国药控股85.88万股,连续7日增持。截止当日收盘,港股通共持有国药控股19177.37万股,占流通股14.29%。国药控股近5个交易日上涨8.40%,港股通累计增持532.19万股;近20个交易日上涨7.97%,港股通累计增持309.84万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042909462887bcb2de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042909462887bcb2de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431494630","title":"国药(01099.HK)拟发行共300亿人币非金融企业债务融资工具","url":"https://stock-news.laohu8.com/highlight/detail?id=2431494630","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2431494630?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:22","pubTimestamp":1714353720,"startTime":"0","endTime":"0","summary":"国药控股公布,为满足公司补充营运及备付资金的实际需求,保证直接融资渠道畅通,降低融资成本并改善债务结构,上周五董事会决议建议在中国境内统一注册发行非金融企业债务融资工具额度,发行规模为300亿元人民币(下同),包括短期品种250亿元及中长期品种50亿元。惟须待股东以特别决议案审议通过及获得相关中国监管机构的批准后,方可实施。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220907154104342_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220907154104342_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345723/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2431043731","title":"国药控股公布第一季度业绩 归母净利润约14.2亿元同比减少10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431043731","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2431043731?lang=zh_cn&edition=full","pubTime":"2024-04-29 08:52","pubTimestamp":1714351942,"startTime":"0","endTime":"0","summary":"国药控股(01099)公布2024年第一季度业绩,营业总收入约1472.66亿元,同比增长1.2%;归属于母公司所有者的净利润约14.2亿元,同比减少10.7%;基本每股收益0.46元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-29/doc-inatncei1536683.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-29/doc-inatncei1536683.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431432060","title":"【港股通】国药控股(01099)首季归母净利同比减少10.7%至14.2亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2431432060","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2431432060?lang=zh_cn&edition=full","pubTime":"2024-04-29 08:44","pubTimestamp":1714351471,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国药控股(01099)公告,截至2024年3月31日止三个月之季度,归母净利录得14.2亿元人民币,同比减少10.7%;营收录得1472.66亿元人民币,同比增长1.2%;基本每股收益0.46元人民币。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200915/NjdlOTQyZDE5NzA3MzU4ZTU3YTk2ZGQ0MjAwMDE4NjcyODIz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NjdlOTQyZDE5NzA3MzU4ZTU3YTk2ZGQ0MjAwMDE4NjcyODIz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935930","is_publish_highlight":false,"gpt_icon":0},{"id":"2431010610","title":"国药控股(01099)拟在中国境内统一注册发行300亿元非金融企业债务融资工具额度","url":"https://stock-news.laohu8.com/highlight/detail?id=2431010610","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2431010610?lang=zh_cn&edition=full","pubTime":"2024-04-29 08:10","pubTimestamp":1714349421,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药控股 公布,为满足公司补充营运及备付资金的实际需求,保证直接融资渠道畅通,降低融资成本并改善债务结构,2024 年 4 月 26 日,董事会决议建议在中国境内统一注册发行非金融企业债务融资工具额度。注册金额为人民币 300 亿元非金融企业债务融资工具额度,其中:短期品种人民币 250 亿元,中长期品种人民币 50 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113830.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431501082","title":"国药控股(01099)公布第一季度业绩 归母净利约14.2亿元 同比减少10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431501082","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431501082?lang=zh_cn&edition=full","pubTime":"2024-04-29 08:06","pubTimestamp":1714349208,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药控股(01099)公布2024年第一季度业绩,营业总收入约1472.66亿元,同比增长1.2%;归属于母公司所有者的净利润约14.2亿元,同比减少10.7%;基本每股收益0.46元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113828.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430621172","title":"国药控股:国药股份一季度净利润4.59亿元 同比增长10.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430621172","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2430621172?lang=zh_cn&edition=full","pubTime":"2024-04-26 08:34","pubTimestamp":1714091682,"startTime":"0","endTime":"0","summary":"国药控股(01099)发布公告,国药股份(600511.SH)于2024第一季度实现营业收入121.22亿元(人民币,下同),同比增长7.98%;归属于上市公司股东的净利润4.59亿元,同比增长10.86%;基本每股收益0.6089元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-26/doc-inatcfte5434502.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-26/doc-inatcfte5434502.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430657402","title":"国药控股(01099):2024年第一季度营收超121亿,净利润同比增10.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430657402","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2430657402?lang=zh_cn&edition=full","pubTime":"2024-04-26 01:11","pubTimestamp":1714065060,"startTime":"0","endTime":"0","summary":"经济学家预测,医药行业的稳步增长将为投资者带来长期利好。国药控股在最新公告中指出,其子公司国药股份于2024年第一季度实现营业收入121.22亿元人民币,同比增长7.98%。与此同时,国药股份的基本每股收益达到0.6089元,展现出公司强劲的盈利能力。综合来看,国药股份在2024年第一季度的业绩表现,为投资者提供了一个清晰的投资参考。在医药行业持续向好的趋势下,国药股份的增长势头,有望带动相关产业链的发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042607010987b0d497&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042607010987b0d497&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430231885","title":"国药(01099.HK)附属国药一致首季净利润3.89亿人民币 增长7.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430231885","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430231885?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:39","pubTimestamp":1714063140,"startTime":"0","endTime":"0","summary":"国药控股(01099.HK) 公布,附属国药一致(000028.SZ) 第一季度报告,营业收入190.9亿人民币(下同),按年增加2.2%。归属股东净利润3.89亿元,增长7.3%,每股收益70分。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-25 16:25。) (A股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/03/22末期业绩普通股息:人民币 0.872023/10/27第三季业绩无派息2023/08/28中期业绩无派息2023/04/28第一季业绩无派息 AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345170/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2430028340","title":"国药控股(01099):国药股份(600511.SH)一季度净利润4.59亿元,同比增长10.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430028340","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430028340?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:23","pubTimestamp":1714051408,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药控股(01099)发布公告,国药股份(600511.SH)于2024第一季度实现营业收入121.22亿元(人民币,下同),同比增长7.98%;归属于上市公司股东的净利润4.59亿元,同比增长10.86%;基本每股收益0.6089元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110603.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430778404","title":"泰通能源拟与国药控股开展融资租赁业务合作 融资金额为2000万","url":"https://stock-news.laohu8.com/highlight/detail?id=2430778404","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2430778404?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:59","pubTimestamp":1714046351,"startTime":"0","endTime":"0","summary":"挖贝网4月25日,泰通能源 近日发布公告,为拓宽融资渠道,满足公司资金需求,公司拟与国药控股 融资租赁有限公司开展融资租赁业务合作,以融资租赁方式,向国药控股融资金额人民币2,000.00万元,期限24个月,以按月支付方式支付租金,具体以实际签订合同为准。本次融资租赁的交易方国药控股(中国)融资租赁有限公司与公司不存在关联关系,不构成关联交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252000568b52eff0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252000568b52eff0&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":-0.0896},{"period":"1month","weight":-0.0453},{"period":"3month","weight":-0.0359},{"period":"6month","weight":0.0124},{"period":"1year","weight":-0.2676},{"period":"ytd","weight":-0.0406}],"compareEarnings":[{"period":"1week","weight":0.0467},{"period":"1month","weight":0.1047},{"period":"3month","weight":0.1894},{"period":"6month","weight":0.046},{"period":"1year","weight":-0.0738},{"period":"ytd","weight":0.0838}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"国药控股股份有限公司主要从事药品及医疗器械分销业务。该公司通过三个业务分部运营。医药分销分部向医院、其他分销商、零售药店及诊所等客户分销药物、医疗器械及医药制品。医药零售分部从事经营医药连锁店业务。其他业务分部从事分销实验室用品、制造及分销化学试剂、以及生产和销售医药制品业务。该公司还通过其子公司在中国从事提供医药物流服务及从事物业租赁业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.002677},{"month":2,"riseRate":0.6,"avgChangeRate":0.035656},{"month":3,"riseRate":0.533333,"avgChangeRate":0.016144},{"month":4,"riseRate":0.4,"avgChangeRate":0.023282},{"month":5,"riseRate":0.533333,"avgChangeRate":-0.012562},{"month":6,"riseRate":0.357143,"avgChangeRate":-0.008776},{"month":7,"riseRate":0.5,"avgChangeRate":-0.010904},{"month":8,"riseRate":0.5,"avgChangeRate":0.015262},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.021807},{"month":10,"riseRate":0.666667,"avgChangeRate":0.048849},{"month":11,"riseRate":0.4,"avgChangeRate":-0.013864},{"month":12,"riseRate":0.533333,"avgChangeRate":-0.00596}],"exchange":"SEHK","name":"国药控股","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药控股,01099,国药控股股票,国药控股股票老虎,国药控股股票老虎国际,国药控股行情,国药控股股票行情,国药控股股价,国药控股股市,国药控股股票价格,国药控股股票交易,国药控股股票购买,国药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}